Old Web
English
Sign In
Acemap
>
authorDetail
>
V.K. Dovger
V.K. Dovger
Gynecology
Benign prostatic hyperplasia (BPH)
Urology
Placebo
Medicine
2
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 30 MG OR 60 MG (SEPARATED BY AT LEAST 12 WEEKS) ADMINISTERED SC TO TREATMENT NAIVE PATIENTS SUFFERING FROM BPH
2008
European Urology Supplements
C. Maclean
L. Skillern
Finn Larsen
A. Gres
A. Strotski
A.V. Dmitrijev
V.K. Dovger
A. Varaksa
Show All
Source
Cite
Save
Citations (4)
346 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 60 MG AT 48 HOURS INTERVAL ADMINISTERED S.C. TO TREATMENT NAÏVE PATIENTS SUFFERING FROM BPH
2007
European Urology Supplements
C. Maclean
Finn Larsen
J Drewe
A.V. Dzmitryieu
A. Gres
A. Strockyi
V.K. Dovger
A. Ulys
A. Černiauskiene
P. Geavlete
M. Nikolovski
Show All
Source
Cite
Save
Citations (5)
1